Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Lagi

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Antimicrobial Chemotherapy|February 10, 2025
Durability of doravirine/dolutegravir dual combination in a multicentre cohort of elderly people with HIVMaria Mazzitelli, Claudia Cozzolino, Cristina Gervasoni, et al.
Viruses|January 22, 2022
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian CohortArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2023
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experienceMatteo Piccica, Michele Spinicci, Annarita Botta, et al.
Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.
International Journal of Transgender Health|April 29, 2024
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, ItalyFilippo Lagi, Claudia Gatteschi, Marta Tilli, et al.
AIDS (London, England)|January 13, 2017
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patientsAlberto Borghetti, Gianmaria Baldin, Amedeo Capetti, et al.
Microbes and Infection|April 18, 2024
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patientsGiulia Nannini, Leandro Di Gloria, Edda Russo, et al.
Antiviral Research|July 9, 2019
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort studyBarbara Rossetti, Gianmaria Baldin, Gaetana Sterrantino, et al.
World Journal of Gastroenterology|March 23, 2022
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapyEdda Russo, Giulia Nannini, Gaetana Sterrantino, et al.
Le Infezioni in Medicina|September 13, 2020
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patientsGiulia Pontecorboli, Filippo Lagi, Mauro Bagli, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Antimicrobial Chemotherapy|February 10, 2025
Durability of doravirine/dolutegravir dual combination in a multicentre cohort of elderly people with HIVMaria Mazzitelli, Claudia Cozzolino, Cristina Gervasoni, et al.
Viruses|January 22, 2022
Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian CohortArturo Ciccullo, Gianmaria Baldin, Vanni Borghi, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2023
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experienceMatteo Piccica, Michele Spinicci, Annarita Botta, et al.
Viruses|May 27, 2023
Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected PatientsMassimiliano Fabbiani, Melissa Masini, Barbara Rossetti, et al.
International Journal of Transgender Health|April 29, 2024
Facilitators and barriers in HIV testing and continuum of care among migrant transgender women who are sex workers residing in Florence, ItalyFilippo Lagi, Claudia Gatteschi, Marta Tilli, et al.
AIDS (London, England)|January 13, 2017
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patientsAlberto Borghetti, Gianmaria Baldin, Amedeo Capetti, et al.
Microbes and Infection|April 18, 2024
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patientsGiulia Nannini, Leandro Di Gloria, Edda Russo, et al.
Antiviral Research|July 9, 2019
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort studyBarbara Rossetti, Gianmaria Baldin, Gaetana Sterrantino, et al.
World Journal of Gastroenterology|March 23, 2022
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapyEdda Russo, Giulia Nannini, Gaetana Sterrantino, et al.
Le Infezioni in Medicina|September 13, 2020
Results of comprehensive cardiovascular diagnostic work-up in HIV positive patientsGiulia Pontecorboli, Filippo Lagi, Mauro Bagli, et al.
Pageof 9